Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac potassium 25 mg for acute ankle sprain pain
2011-005577-23Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Ankle sprain comparing Voltaren Dolo extra with Placebo (2 arms). Primary endpoint: Ankle pain on movement at 48 hours. Started May 2012; status: completed.
02
Drugs
diclofenac potassium
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2011-005577-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005577-23.